| Zebrafish: an emerging model system for human disease and drug discovery G Kari, U Rodeck, AP Dicker Clinical Pharmacology & Therapeutics 82 (1), 70-80, 2007 | 575 | 2007 |
| The EGF receptor–an essential regulator of multiple epidermal functions M Jost, C Kari, U Rodeck European Journal of Dermatology 10 (7), 505-10, 2000 | 413 | 2000 |
| Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. HD Menssen, HJ Renkl, U Rodeck, J Maurer, M Notter, S Schwartz, ... Leukemia 9 (6), 1060-1067, 1995 | 360 | 1995 |
| Regulation of NK cell functions by TGF-beta 1. G Bellone, M Aste-Amezaga, G Trinchieri, U Rodeck Journal of immunology (Baltimore, Md.: 1950) 155 (3), 1066-1073, 1995 | 330 | 1995 |
| Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis DA Erkes, W Cai, IM Sanchez, TJ Purwin, C Rogers, CO Field, AC Berger, ... Cancer discovery 10 (2), 254-269, 2020 | 327 | 2020 |
| Tumor-associated transforming growth factor-β and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients G Bellone, A Turletti, E Artusio, K Mareschi, A Carbone, D Tibaudi, ... The American journal of pathology 155 (2), 537-547, 1999 | 316 | 1999 |
| Biology of tumor progression in human melanocytes. M Herlyn, WH Clark, U Rodeck, ML Mancianti, J Jambrosic, H Koprowski Laboratory Investigation; a Journal of Technical Methods and Pathology 56 (5 …, 1987 | 301 | 1987 |
| Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage C Kari, TO Chan, M Rocha de Quadros, U Rodeck Cancer research 63 (1), 1-5, 2003 | 242 | 2003 |
| Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma KM Amin, LA Litzky, WR Smythe, AM Mooney, JM Morris, DJY Mews, ... The American journal of pathology 146 (2), 344, 1995 | 242 | 1995 |
| Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. EM Rakowicz-Szulczynska, U Rodeck, M Herlyn, H Koprowski Proceedings of the National Academy of Sciences 83 (11), 3728-3732, 1986 | 242 | 1986 |
| Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1 I Shin, AV Bakin, U Rodeck, A Brunet, CL Arteaga Molecular biology of the cell 12 (11), 3328-3339, 2001 | 236 | 2001 |
| EGF-R dependent regulation of keratinocyte survival U Rodeck, M Jost, C Kari, DT Shih, RM Lavker, DL Ewert, PJ Jensen Journal of Cell Science 110 (2), 113-121, 1997 | 220 | 1997 |
| Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. U Rodeck, K Melber, R Kath, HD Menssen, M Varello, B Atkinson, ... Journal of investigative dermatology 97 (1), 20-26, 1991 | 219 | 1991 |
| Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects U Rodeck, M Herlyn, D Herlyn, C Molthoff, B Atkinson, M Varello, ... Cancer research 47 (14), 3692-3696, 1987 | 217 | 1987 |
| Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma K Ge, J DuHadaway, W Du, M Herlyn, U Rodeck, GC Prendergast Proceedings of the National Academy of Sciences 96 (17), 9689-9694, 1999 | 214 | 1999 |
| In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model B Daroczi, G Kari, MF McAleer, JC Wolf, U Rodeck, AP Dicker Clinical Cancer Research 12 (23), 7086-7091, 2006 | 213 | 2006 |
| Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway M Jost, TM Huggett, C Kari, LH Boise, U Rodeck Journal of Biological Chemistry 276 (9), 6320-6326, 2001 | 203 | 2001 |
| Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide U Murthy, A Basu, U Rodeck, M Herlyn, AH Ross, M Das Archives of biochemistry and biophysics 252 (2), 549-560, 1987 | 200 | 1987 |
| Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. S Szala, Y Kasai, Z Steplewski, U Rodeck, H Koprowski, AJ Linnenbach Proceedings of the National Academy of Sciences 87 (17), 6833-6837, 1990 | 190 | 1990 |
| Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. B Westermark, A Johnsson, Y Paulsson, C Betsholtz, CH Heldin, M Herlyn, ... Proceedings of the National Academy of Sciences 83 (19), 7197-7200, 1986 | 189 | 1986 |
George C PrendergastProfessor, President & CEO, Lankenau Institute for Medical Research在 limr.org 的电子邮件经过验证
